Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Halozyme Therapeutics Inc. buy Morgan Stanley

Halozyme Therapeutics Inc.
Start price
€40.11
10.08.23 / 50%
Target price
€55.35
10.08.24
Performance (%)
26.55%
End price
€50.76
11.08.24
Summary
This prediction ended on 11.08.24 with a price of €50.76. The prediction had a final performance of 26.55%. Morgan_Stanley has a follow-up prediction for Halozyme Therapeutics Inc. where he still thinks Halozyme Therapeutics Inc. is a Buy. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Halozyme Therapeutics Inc. 0.799% 0.799% 28.007%
iShares Core DAX® 0.224% 2.457% 21.634%
iShares Nasdaq 100 0.371% -0.320% 5.422%
iShares Nikkei 225® 0.972% -0.829% 15.333%
iShares S&P 500 0.417% -0.157% 3.125%

Comments by Morgan_Stanley for this prediction

In the thread Halozyme Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) 26.55%
Target price 55.345
Change
Ends at 10.08.24

Halozyme Therapeutics, Inc. (NASDAQ: HALO) had its price target raised by analysts at Morgan Stanley from $60.00 to $61.00. They now have an "overweight" rating on the stock.
Ratings data for HALO provided by MarketBeat

Morgan Stanley 
0
Report Share
10.08.23
In the thread Trading Halozyme Therapeutics Inc.
Prediction Buy
Perf. (%) 26.55%
Target price 55.345
Change
Ends at 10.08.24

Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten

Morgan Stanley 
0
Report Share
11.08.24

Current prediction by Morgan_Stanley for Halozyme Therapeutics Inc.

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€54.00
06.08.25
€64.83
06.08.26
7.41%
23.12.25

Morgan Stanley 
06.08.25 50%

Stopped prediction by Morgan_Stanley for Halozyme Therapeutics Inc.

buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€57.80
20.10.25
€67.75
20.10.26
0.35%
23.12.25

Morgan Stanley 
20.10.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€58.38
18.08.25
€68.36
18.08.26
-0.65%
23.12.25

Morgan Stanley 
18.08.25 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€49.79
07.08.24
€58.59
07.08.25
6.69%
08.08.25

Morgan Stanley 
07.08.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€34.03
26.12.23
€53.50
26.12.24
34.94%
27.12.24

Morgan Stanley 
26.12.23 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.50
06.03.23
€60.06
06.03.24
-10.61%
07.03.24

Morgan Stanley 
06.03.23 50%